The positive is that NPAT guidance is unchanged and 2H21 is expected to deliver ~2.5 times 1H21 NPAT
The negative it calling professional services from ongoing client demand is 'attached recurring revenue'......it declined over the last two 6 month reporting periods so is that really that reliable to term recurring.....I'm sure there is a better way to express this, because it looks like an own goal to class this as 'recurring revenue' when it has declined for a SaaS company.
The other point of concern is that R&D capitalised increased significantly in 1H21......R&D in itself is not bad, but was this capitalised to make the 1H21 results look better than reported.....perhaps legit, and perhaps they redeployed project staff into R&D but interesting to see how this looks in 2H21.
Anyway, FY 2021 NPAT of 32-35m means EPS of 13-14c and a PE of 21-23 on FY2021 earnings...nNot necessarily expensive, but perhaps appropriate given the growth reflected in the last 9 months.
2H21 project fees will highlight a turnaround I think
- Forums
- ASX - By Stock
- BVS
- Ann: Investor Presentation
Ann: Investor Presentation, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BVS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.38 |
Change
0.030(2.22%) |
Mkt cap ! $614.2M |
Open | High | Low | Value | Volume |
$1.36 | $1.39 | $1.35 | $662.2K | 484.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 277 | $1.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.39 | 6629 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 11783 | 1.375 |
4 | 17450 | 1.370 |
10 | 12796 | 1.365 |
5 | 7573 | 1.360 |
4 | 2914 | 1.355 |
Price($) | Vol. | No. |
---|---|---|
1.380 | 2521 | 9 |
1.385 | 4055 | 5 |
1.390 | 22322 | 6 |
1.395 | 2350 | 4 |
1.400 | 13533 | 5 |
Last trade - 15.37pm 30/09/2024 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |